Evotec SE (EVO) Current Assets (2009 - 2026)
Evotec SE's (EVO) quarterly Current Assets came in at $847.2 million in Q2 2026, up 23.83% year-over-year from $684.2 million in Q2 2025, and up 1.74% quarter-over-quarter from $832.7 million in Q1 2026.
Analysis
Evotec SE (EVO) Current Assets (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Current Assets across 9 years of filings, most recently posting $847.2 million for Q2 2026.
- In Q2 2026, Current Assets rose 23.83% year-over-year to $847.2 million; the TTM figure through Jun 2026 stood at $847.2 million (up 23.83% YoY), while the FY2025 annual figure was $862.0 million, up 16.78% from the prior year.
- Current Assets came in at $847.2 million for Q2 2026 at Evotec SE, up from $832.7 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $1.2 billion in Q1 2022 to a low of $684.2 million in Q2 2025.
- Average Current Assets over 5 years is $915.4 million, with a median of $892.8 million recorded in 2024.
- Year-over-year, Current Assets jumped 49.12% in 2022 and decreased 25.01% in 2024.
- Over 5 years, Current Assets stood at $1.1 billion in 2022, then fell by 11.29% to $971.7 million in 2023, then slipped by 25.01% to $728.7 million in 2024, then increased by 21.87% to $888.1 million in 2025, then retreated by 4.6% to $847.2 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $847.2 million in Q2 2026, $832.7 million in Q1 2026, and $888.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 6.23 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 1.05 Bn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 1.53 Bn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 3.75 Bn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 923.60 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 847.23 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 332.54 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 19.22 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 11.83 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 3.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 847.23 Mn |
| Mar 31, 2026 | 832.73 Mn |
| Dec 31, 2025 | 888.10 Mn |
| Sep 30, 2025 | 927.20 Mn |
| Jun 30, 2025 | 684.21 Mn |
| Mar 31, 2025 | 761.43 Mn |
| Dec 31, 2024 | 728.74 Mn |
| Sep 30, 2024 | 766.67 Mn |
| Mar 31, 2024 | 897.49 Mn |
| Dec 31, 2023 | 971.75 Mn |
| Jun 30, 2023 | 1.12 Bn |
| Dec 31, 2022 | 1.10 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Mar 31, 2022 | 1.19 Bn |
| Dec 31, 2021 | 1.26 Bn |
| Sep 30, 2021 | 740.95 Mn |
| Dec 31, 2020 | 785.53 Mn |
| Sep 30, 2010 | 104.39 Mn |
| Jun 30, 2010 | 102.08 Mn |
| Mar 31, 2010 | 91,555.63 |